Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Total Non-Current Liabilities came in at $217.8 million in Q2 2026, down 11.11% on a YoY basis from $245.0 million in Q2 2025, and down 6.95% quarter-over-quarter from $234.0 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Total Non-Current Liabilities for 16 consecutive years, with $217.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 11.11% year-over-year to $217.8 million; the trailing twelve-month figure through Jun 2026 stood at $217.8 million (down 11.11% YoY), and the FY2025 full-year result was $227.7 million, down 17.24% from the prior year.
- Total Non-Current Liabilities fell to $217.8 million in Q2 2026 per UFPT's latest filing, from $234.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $298.4 million in Q3 2024 and bottomed at $98.8 million in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $181.0 million across 5 years, with a median of $155.9 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 460.24% in 2022, then declined 26.35% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $122.4 million in 2022, then decreased by 15.98% to $102.9 million in 2023, then soared by 167.43% to $275.1 million in 2024, then slipped by 17.24% to $227.7 million in 2025, then dropped by 4.34% to $217.8 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $217.8 million, $234.0 million, and $227.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 217.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.78 Mn |
| Mar 31, 2026 | 234.05 Mn |
| Dec 31, 2025 | 227.68 Mn |
| Sep 30, 2025 | 244.63 Mn |
| Jun 30, 2025 | 245.00 Mn |
| Mar 31, 2025 | 273.15 Mn |
| Dec 31, 2024 | 275.09 Mn |
| Sep 30, 2024 | 298.42 Mn |
| Jun 30, 2024 | 102.46 Mn |
| Mar 31, 2024 | 98.84 Mn |
| Dec 31, 2023 | 102.86 Mn |
| Sep 30, 2023 | 112.39 Mn |
| Jun 30, 2023 | 123.12 Mn |
| Mar 31, 2023 | 124.82 Mn |
| Dec 31, 2022 | 122.43 Mn |
| Sep 30, 2022 | 142.61 Mn |
| Jun 30, 2022 | 167.18 Mn |
| Mar 31, 2022 | 144.71 Mn |
| Dec 31, 2021 | 124.50 Mn |
| Sep 30, 2021 | 28.86 Mn |